Platelet-associated complement factor H in healthy persons and patients with atypical HUS.
about
Atypical hemolytic uremic syndromeProperdin: a tightly regulated critical inflammatory modulatorAn imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD)Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy.Novel developments in thrombotic microangiopathies: is there a common link between hemolytic uremic syndrome and thrombotic thrombocytic purpura?Current evidence for the role of complement in the pathogenesis of Shiga toxin haemolytic uraemic syndrome.Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studiesEculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS.Minor Role of Plasminogen in Complement Activation on Cell Surfaces.HUS and atypical HUS.Treatment of Atypical Hemolytic-Uremic Syndrome in the Era of Eculizumab.Complement control protein factor H: the good, the bad, and the inadequate.Regulatory components of the alternative complement pathway in endothelial cell cytoplasm, factor H and factor I, are not packaged in Weibel-Palade bodies.The VPS33B-binding protein VPS16B is required in megakaryocyte and platelet α-granule biogenesis.Identification of a novel mode of complement activation on stimulated platelets mediated by properdin and C3(H2O).Polyphosphate suppresses complement via the terminal pathway.Reincarnation of ancient links between coagulation and complement.Discrepant platelet and plasma von Willebrand factor in von Willebrand disease patients with p.Pro2808Leufs*24.Complement Activation Induces Neutrophil Adhesion and Neutrophil-Platelet Aggregate Formation on Vascular Endothelial Cells.Haemostasis and innate immunity - a complementary relationship: A review of the intricate relationship between coagulation and complement pathways.
P2860
Q21202864-4CEA2438-B3FD-4131-BF93-95821BD1A887Q28069187-A26103AA-28CB-4312-B59F-70F031A7F6E2Q28293350-48D3FF1F-9A78-4DBF-9DDE-AA3CCB31DAFEQ33392316-F0F901C5-A3A2-4C81-85F3-7690E187C69EQ33395774-09F4E257-B55B-460B-8386-49A09B20D8BCQ33409030-79834FA0-F568-4DB8-A98A-E4B73A05AB13Q33420172-6BAC0C7D-9F5F-4872-8F78-944E6B07A67DQ33421669-501E7184-F640-4B69-A944-F541B01BD20EQ33428157-6C2325F9-DA2B-40AF-8CD5-F731B91F5C09Q33441069-446DEE01-8087-46A6-8A62-7FFAD2A8873AQ33441329-12897565-73C2-4707-B5B4-ABC23EA926AAQ34067107-49E052F0-8D21-41EB-92A3-FFA0EC697B61Q35585484-811D95EE-DF6F-433C-86F9-09837153072CQ36514469-1933F4CD-7539-4529-B5F2-0CA780A6E538Q37200463-894202D4-0739-4BD6-AB56-03703A4661E1Q37535268-2E623FBC-8134-492F-97A0-FB2F23181129Q38543278-29EBA075-1711-49CD-BE82-9464D1E8405AQ38814362-8D9937B1-A53B-45C6-A226-D3EBEAE7F59FQ45696232-C12E88FF-EB96-4283-B7FB-8C78955BF94CQ48371887-6AA7EA30-789E-4CBA-872A-B58AA29A684C
P2860
Platelet-associated complement factor H in healthy persons and patients with atypical HUS.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Platelet-associated complement ...... nd patients with atypical HUS.
@ast
Platelet-associated complement ...... nd patients with atypical HUS.
@en
type
label
Platelet-associated complement ...... nd patients with atypical HUS.
@ast
Platelet-associated complement ...... nd patients with atypical HUS.
@en
prefLabel
Platelet-associated complement ...... nd patients with atypical HUS.
@ast
Platelet-associated complement ...... nd patients with atypical HUS.
@en
P2093
P1433
P1476
Platelet-associated complement ...... nd patients with atypical HUS.
@en
P2093
Bernd Hoppe
Christoph Licht
Denis F Geary
Hilary Christensen
Peter F Zipfel
Sandra Habbig
Walter H A Kahr
P304
P356
10.1182/BLOOD-2009-03-205096
P407
P577
2009-08-24T00:00:00Z